Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04363671
Other study ID # P20-670
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 2020
Est. completion date December 2020

Study information

Verified date April 2020
Source Hôpital Cochin
Contact Emilie Carretier, MD
Phone +33 (0)158412814
Email emilie.carretier@aphp.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Maison des Adolescents (MDA) at Cochin Hospital (Paris) is a multidisciplinary service which welcomes adolescents in three different units: consultation, day care and hospitalization. However, the epidemic of coronavirus (COVID-19) in March 2020 which imposed the extreme limitation of contacts and then the confinement of the entire population, required urgent adaptation of care practices. Teleconsultation quickly became essential for most consultations (psychiatrists, psychologists, nurses, but also pediatricians and somatic physicians). In day hospital, daily reception could not be carried out, therapeutic workshops, family interviews, or speaking groups were organized remotely. In hospital unit, the interruption of visits required the organization of remote interviews with families. Far from the comfort of an organized and structured telepsychiatry, the use of videoconferencing was done in an emergency and without preparation. The objective is to explore the experience of adolescents, doctors and psychologists regarding emergency changes in the methods of their follow-up by setting up teleconsultation in the context of the COVID-19 epidemic.


Description:

The study will be monocentric, exploratory, and qualitative based on the Interpretative Phenomenological Analysis. 15 adolescents followed in consultation, day hospital or full hospitalization and 15 health professionals working at the Maison des Adolescents will be included. Semi-structured interviews will be carried out by a psychiatrist, based on flexible and evolving interview guides. Qualitative analysis of adolescents and therapists' interviews will allow to explore the experience of teleconsultation by each group of participants and to inform about the advantages and limits of a teleconsultation device in adolescent care.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date December 2020
Est. primary completion date June 2020
Accepts healthy volunteers No
Gender All
Age group 11 Years and older
Eligibility Inclusion Criteria:

- adolescents aged between 11 and 20 years who benefit from follow-up in the structure (at least two face-to-face consultations before setting up teleconsultations) and for whom their follow-up had to be changed urgently in the form of teleconsultation from March 2020 as part of the COVID-19 epidemic. Adolescents will be included in the various consultation, day hospitalization and full hospitalization units. The pathologies will be varied so as to cover different situations and experiences: eating disorders, mood disorders, personality disorders, anxiety disorders, or even chronic somatic illness.

- health professionals working at the Maison des Adolescents at the time of the epidemic, from different specialties (psychiatrists, pediatricians, psychologists, nurses, etc.) and units (consultations, day hospitalization, full hospitalization).

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Maison de Solenn, Cochin Hospital Paris

Sponsors (2)

Lead Sponsor Collaborator
Hôpital Cochin Institut National de la Santé Et de la Recherche Médicale, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Exploration of themes emerging from analysis of the content of the interview with the adolescents and therapists To describe the experience of reorganization of care during the COVID-19 epidemic and acceptability of teleconsultation for the adolescents and the therapists. six months
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure